Supreme Court on Wednesday said that the Central Government has approved the use of Remdesivir and Fabiparivir medicine for the treatment of COVID-19.
The Supreme Court on Wednesday said that the Central Government has approved the use of Remdesivir and Fabiparivir medicine to treat COVID- 19. The apex court after hearing an appeal in lieu of registering FIR by the Central Bureau of Investigation against ten Indian Pharmaceutical firms for manufacturing and selling these two medicines for allegedly treating COVID-10 patients without a valid license. These antiviral drugs have become a matter of debate among medical experts.
A bench comprising Chief Justice S.A Bobde and Justices A S Bopanna and V Ramasubramanian referred to the New Drugs and Clinical Trials Rules, 2018 and said these medicines ha e been permitted by the government for using the Coronavirus patients. ” You have not noticed the rule and filed this petition. We are adjourning this matter, you see the rules and then come back,” the bench told lawyer M Sharma who has filed the PIL.
After hearing the plea for two weeks the bench said,” There is approval by the Government of India for Remdesivir and Fabiparivir”. The PIL said that these medicines have not been certified as medicines for COVID-19 till date by any country.
Seeking CBI investigation, Sharma had filed PIL alleging that these two medicines have been wrongly manufactured for COVID-19 patients without any licence from the central drugs standard control organisation. Bench from supreme court given the statement ” they are under trials and no country, including India have issued a licence to manufacture and sale them in the country.
Remdesivir was introduced by Gilead Science Inc. USA to treat Ebola virus in Africa. However, it did not work. Whereas, Fabiparivir was introduced by Fujifilm Toyama Chemical to treat Influenza. The PIL has made ministry of Health and family welfare and the central drugs standard control organisation as parties including 10 pharmaceutical companies named as Cipla Ltd, Dr. Reddy’s laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd as parties.
In this growing pandemic, scientist, researches, doctors, laboratories throughout the world are working under pressure to manufacture antidot for this virus and it is claimed that we will get the drug by the end of this year.